Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates

A preventive human immunodeficiency virus type 1 (HIV-1) vaccine is an essential part of the strategy to eradicate AIDS. A critical question is whether antibodies that do not neutralize primary isolate (tier 2) HIV-1 strains can protect from infection. In this study, we investigated the ability of a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Saunders, Kevin O., Santra, Sampa, Parks, Robert, Yates, Nicole L., Sutherland, Laura L., Scearce, Richard M., Balachandran, Harikrishnan, Bradley, Todd, Goodman, Derrick, Eaton, Amanda, Stanfield-Oakley, Sherry A., Tartaglia, James, Phogat, Sanjay, Pantaleo, Giuseppe, Esteban, Mariano, Gomez, Carmen E., Perdiguero, Beatriz, Jacobs, Bertram, Kibler, Karen, Korber, Bette, Montefiori, David C., Ferrari, Guido, Vandergrift, Nathan, Liao, Hua-Xin, Tomaras, Georgia D., Haynes, Barton F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874432/
https://ncbi.nlm.nih.gov/pubmed/29437967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02035-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados